Table 2.
Sample Type | Focus | Sample Composition | Sample Concentration/ Flow-rate/Cell Throughput | Acquisition Conditions (Frequencies, Voltage & Channel cross-section) | Characterization Metrics & Methods | Ref. |
---|---|---|---|---|---|---|
Algae | Viability assessment of bacterium-sized green algae |
Picochlorum SE3 algae (~2–3 μm cell diameter); (ref. particles: *PS beads) |
†NCCD ‡NFRD |
500 kHz to 30 MHz (8 simultaneous frequencies) §NSVD 30 μm × 8 μm |
Magnitude & Opacity (Magnitude 20 MHz/Magnitude 500 kHz) | Sui et al. 202055 |
C. elegans | Identification of C. elegans developmental stages |
C. elegans (~200 μm – 1.2 mm length) |
†NCCD 30 μL/min |
300 kHz 1.5 V amplitude 160 μm × 130 μm |
Transit Time & Magnitude | Zhu et al. 2018108 |
Cancer Cells | Discrimination of dissociated tumour cell lines from major cancer types | Lung, thyroid, breast, ovarian, and kidney normal and cancer cells (~10–20 μm cell diameter); (testing particles: peripheral blood mononucleated cells, RBCs) |
†NCCD 50 μL/min |
250 kHz §NSVD 25 μm × 25 μm |
Transit-time & Signal peak-to-peak voltage | Desai et al. 2019194 |
Cancer Cells | Characterization of phenotypical properties of circulating tumour cells | Lung cancer cell lines A549 and MLO-Y4; Isolated CTCs from hepatic, oral and lung cancer (~10–20 μm cell diameter) |
2 × 104 cells/mL 50, 100 and 150 μL/h |
1 kHz & 100 kHz §NSVD 6–10 μm × 6–10 μm |
Transit-time, Magnitude, Phase & Dielectric Properties (Cmem & σcyt); Equivalent Circuit Models |
Chiu et al. 2017162 |
Cancer Cells | Characterization of phenotypical properties of tumour cell lines | Lung cancer cell line A549, Adenoid carcinoma cell line SACC-83 and lung metastasis cell line SACC-LM (~10–20 μm cell diameter) |
5 × 106 cells/mL ‡NFRD |
100 kHz & 250 kHz §NSVD 11 μm × 9 μm |
Transit-time, Magnitude, Phase & Dielectric Properties (Cmem & σcyt); Equivalent Circuit Models |
Zhang et al. 2019163 |
Cancer Cells | Characterization of phenotypical properties of single-nuclei | Nuclei from cancer cell lines A549 and SW620 | 1 × 106 nuclei/mL ‡NFRD |
1 kHz to 250 kHz 0.2 V amplitude 5–8 μm × 5–7 μm |
Magnitude, Phase & Dielectric Properties (Cne, Rne, & Rnp); Equivalent Circuit Models |
Liang et al. 2019165 |
Cancer Cells | Characterization of pancreatic tumourigenicity phenotypes | Pancreatic tumour xenografts from metastatic (T366 and T608) vs. primary cancer of mutant genotype (T449 and T395) and wild type (T738 and T188) (~12–20 μm cell diameter); (ref. particles: 7 μm *PS beads) |
2 × 105 cells/mL 1.2 × 105 beads/mL 100 μL/min |
500 kHz, 18.3 MHz & 250 kHz to 50 MHz (24 frequencies) 6 V amplitude 60 μm × 30 μm |
Real, Imaginary, Magnitude, Phase, Electrical Diameter, Opacity (Magnitude 2MHz/Magnitude 500 kHz) & Contrast (Phase 50MHz/Phase 500kHz); 2D Gaussian gating |
McGrath et al. 201971 |
Cancer Cells | Characterization of phenotypical properties of tumour cell lines with epithelial-mesenchymal transitions. | Lung cancer cell lines A549 & H1299; (testing particles: HeLa model cell line) (~10–40 μm cell diameter) |
3–5 × 106 cells/mL ‡NFRD |
100 kHz & 250 kHz §NSVD 10 μm × 12 μm |
Transit-time, Magnitude, Phase & Dielectric Properties (Cmem & σcyt); Equivalent Circuit Models & Neural Network Pattern Recognition (two-layer feed forward) |
Zhao et al. 2018154 |
Human Pathogens | Detection and enumeration of Gram-positive and Gram-negative bacteria | Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli (~1 μm cell diameter and 2–3 μm × 0.5 μm, respectively); (ref. particles: 1 and 2 μm *PS beads) |
2–2.5 × 106 particles/mL 0.01 μL/min |
200 kHz, 7 MHz & 8 MHz 3 V amplitude 10 μm × 10 μm |
Magnitude, Phase & Opacity (Magnitude 7 MHz / Magnitude 200 kHz) | Clausen et al. 201840 |
Human Pathogens | Viability assessment and species discrimination of water-borne pathogens |
Cryptosporidum parvum, Cryptosporidum muris and Giardia lamblia (~4 μm, ~6 μm and 9 μm cell diameter, respectively); (ref. particles: 7 μm *PS beads) |
1 × 105 cells/mL 1 × 105 beads/mL 40 μL/min |
18.3 MHz & 250 kHz to 50 MHz (24 frequencies) 1 to 10 V amplitude 40 μm × 30 μm |
Real, Imaginary, Magnitude & Phase; 2D Gaussian gating & Multi-shell Modelling |
McGrath et al. 2017151 |
Human Pathogens | Characterization of phenotypical properties of Plasmodium falciparum-infected RBCs |
Plasmodium falciparum-infected RBCs and uninfected RBCs (~7.5 μm × 2 μm); (ref. particles: 7 μm *PS beads) |
5 × 105 cells/mL 1 × 105 beads/mL 40 μL/min |
18.3 MHz & 250 kHz to 50 MHz (24 frequencies) §NSVD 40 μm × 30 μm |
Real, Imaginary, Magnitude, Phase & Fluorescence; Multi-shell Modelling |
Honrado et al. 201869 |
Human Pathogens | Detection of susceptibility of host microbiota to bacterial spore germination |
Clostridioides difficile in spore and vegetative form (~0.5 μm diameter and ~2–5 μm × 0.5 μm, respectively); (ref. particles: 2 μm *PS beads) |
†NCCD 10 μL/min |
0.5, 2 & 10 MHz 0.5 V amplitude 30 μm × 30 μm |
Magnitude & Phase | Moore et al. 2020153 |
HUVECs | Viability assessment of hypertonic stimulated cells | Human umbilical vein endothelial cells – HUVECs, human colon cancer (HT-29) cells and immature bone-marrow-derived macrophages (iBMDM) (~10–20 μm cell diameter); (testing particles: 5, 10 and 15 μm *PS beads) |
1 × 105 cells/mL 0.3–1.7 × 105 beads/mL 20 μL/min |
450 kHz 5 V amplitude 20 μm × 20 μm |
Magnitude | Zi et al. 2020119 |
Model Cell Lines | Discrimination of live, necrotic and apoptotic cells | HeLa and Jurkat model cell lines (~10–40 μm cell diameter); (ref. particles: 3, 5, 7 and 10 μm *PS beads) |
1–10 × 106 particles/mL −200 μL/min |
1 MHz 0.3 V amplitude 25 μm × 12 μm |
Conductance, Susceptance, Magnitude & Phase | Xie et al. 201749 |
Model Cell Lines | Combined impedance flow cytometry (IFC) and electrical impedance spectroscopy (EIS) for cell analysis | HeLa, HepG2 and A549 model cell lines (~10–40 μm cell diameter); (ref. particles: 6 μm *PS beads) |
1 × 106 cells/mL 10 nL/min |
IFC: 1 MHz EIS: 1 – 103 kHz 1 V amplitude 30 μm × 20 μm |
Magnitude; Equivalent Circuit Models |
Feng et al. 2019129 |
Model Cell Lines | Discrimination of live, necrotic and apoptotic cells | Lymphoma model cell line U937 (~13 μm cell diameter); (ref. particles: 10 μm *PS beads) |
†NCCD ‡NFRD |
500 kHz, 2 MHz, 6 MHz & 12 MHz §NSVD 50 μm × 50 μm |
Magnitude & Phase | Ostermann et al. 202041 |
Model Cell Lines | Discrimination of live, necrotic and apoptotic cells | Lymphoma model cell line U937 (~13 μm cell diameter); (ref. particles: 6 μm *PS beads) |
10 μL/min 200 cells/s |
500 kHz & 10 MHz 5 V amplitude 40 μm × 21 μm |
Electrical diameter & Phase; Multi-shell Modelling |
De Ninno et al. 202064 |
Model Cell Lines | Characterization of deformability and impedance phenotypes of cancer cells | Normal, fixed and PMA-modified model MCF-7 cells (~15–25 μm cell diameter); (ref. particles: RBCs) |
0.5–1 × 106 cells/mL 1000 cells/min |
1 MHz 0.5 V amplitude 10 μm × 20 μm |
Time metrics & Magnitude | Zhou et al. 2018116 |
Model Cell Lines | Characterization of biophysical and impedance phenotypes of cancer cells | Model cell lines (H460, H446, A549, 95D and 95C) (~10–20 μm cell diameter) |
1 × 106 cells/mL ‡NFRD |
1 kHz & 100 kHz §NSVD 10 μm × 10 μm |
Extracted Properties (Young’s modulus, electrical diameter, Cmem & σcyt); Equivalent Circuit Models |
Wang et al. 2017156 |
Model Cell Lines | Characterization of deformability and impedance phenotypes of cancer cells | Model MCF-7 cell line (~15–25 μm cell diameter) |
>430 cells/min | 50 kHz 2 V amplitude 10 μm × 20 μm |
Transit-time, Magnitude; Neural Network Pattern Recognition (three-layer back propagation) |
Yang et al. 2019115 |
Model Cell Lines | Viability assessment of drug-treated cancer cells | Model T47D cell line (~10–20 μm cell diameter) |
4 × 105 cells/mL ‡NFRD |
500 kHz & 300 kHz to 30 MHz (4 simultaneous frequencies); §NSVD 100 μm × 30 μm |
Magnitude, Phase; Neural Network Pattern Recognition (support vector machines) |
Ahuja et al. 201953 |
Pollen | Viability assessment of pollen | Tobacco (Nicotiana tabacum), tomato (Solanum lycopersicum), cucumber (Cucumis sativus) and pepper (Capsicum Annuum) pollen (~15–150 μm cell diameter) (testing particles: 10, 20, 30, 60 and 100 μm *PS beads) | 5 × 104−5 cells/mL 1–5 × 104 beads/mL ‡NFRD |
500 kHz, 3 MHz & 12 MHz §NSVD 120–250 μm × 120–250 μm |
Magnitude & Phase | Heidmann et al. 2016169 |
Red Blood Cells | Characterization of phenotypical properties of individual RBCs | RBCs, sphericallized RBCs, RBCs ghosts (~7.5 μm × 2 μm) (ref. particles: 7 μm *PS beads) |
5 × 105 cells/mL 40 μL/min |
18 MHz & 250 kHz to 80MHz (8 simultaneous frequencies) 4 V amplitude 40 μm × 30 μm |
Real, Imaginary, Magnitude, Phase & Dielectric Properties (Electrical Radius, Cmem, εcyt & σcyt); Multi-shell Modelling |
Spencer & Morgan 202089 |
Stem Cells | Characterization of phenotypical properties of skeletal stem cells after enrichment and expansion | Patient-derived skeletal stem cells & human bone marrow mononuclear cells – hBMMNCs (~5–30 μm cell diameter); (ref. particles: 7 μm *PS beads |
2–2.5 × 105 cells/mL 0.5–1 × 105 beads/mL 40 μL/min |
500 kHz & 2 MHz 4 V amplitude 40 μm × 30 μm |
Electrical diameter, Opacity (Magnitude 2MHz / Magnitude 500 kHz) & Fluorescence | Xavier et al. 2017161 |
White Blood Cells | Detection and profiling of activated T-lymphocytes | Unstimulated CD8+ T-lymphocytes, activated CD8+-CD69+ T-lymphocytes, non-activated CD8+-CD69− T-lymphocytes (~5–15 μm cell diameter); (ref. and testing particles: 8, 10 and 15 μm *PS beads) |
3–5 × 105 cells/mL 5 × 105 beads/mL 1 μL /min 400 cells/min |
100 kHz to 27 MHz (6 simultaneous frequencies) 0.4 V amplitude 30 μm × 50 μm |
Real & Imaginary | Rollo et al. 201779 |
White Blood Cells | Detection and profiling of white blood cells post inertial-based separation | Lymphocytes, monocytes and neutrophils (~5–20 μm cell diameter); (testing particles: diluted whole blood and peripheral blood mononucleated cells) |
1 × 106 cells/mL 5 μL /min |
300 kHz & 1.7 MHz 3 V amplitude 30 μm × 20 μm |
Magnitude & Opacity (Magnitude 1.7 MHz / Magnitude 300 kHz) |
Petchakup et al. 201860 |
White Blood Cells | Detection and profiling of neutrophils post integrated inertial-based separation of white blood cells | Lymphocytes, monocytes and neutrophils (testing particles: peripheral blood mononucleated cells) (~5–20 μm cell diameter); (ref. particles: 10 μm *PS beads) |
1–5 × 105 cells/mL 1–2.5 × 104 beads/mL ~800 cells/min |
300 kHz & 1.7 MHz §NSVD 30 μm × 20 μm |
Electrical diameter & Opacity (Magnitude 1.7 MHz / Magnitude 300 kHz) | Petchakup et al. 201963 |
White Blood Cells | Characterization of deformability and impedance phenotypes of diabetic lymphocytes | Normal and diabetic-activated lymphocytes (~5–15 μm cell diameter); (testing particles: normal and fixed RBCs) |
4 × 106 cells/mL 50 μL /h |
800 kHz 0.1 V amplitude 10 μm × 5–15 μm |
Transit-time & Magnitude | Mahesh et al. 2019145 |
Yeast Cells | Viability assessment of drug-treated yeast cells and insect cells | Yeast cells (Saccharomyces cerevisiae carlsbergensis) (~4–40 μm cell diameter); Normal and baculovirus-infected Sf9 insect cell |
1 × 105−7 cells/mL 500 to 1000 cells/s |
500 kHz, 10 MHz & 12 MHz §NSVD 30–50 μm × 30–50 μm |
Magnitude & Phase | Opitz et al. 201972 |
Yeast Cells | Detection and cell shape phenotyping of single buddying yeast cells | Buddying yeast cells (Saccharomyces cerevisiae) (~4–40 μm cell diameter); (testing particles: 5 and 8 μm *PS beads; 8 and 15 μm by 4 μm SU-8 rods) |
107 cells/mL 40 μL/min ~3–6 cells/s |
1 MHz 0.2 V amplitude 17 μm × 12 μm |
Particle shape metrics & Magnitude; | Xie et al.201988 |
Yeast Cells | Dielectrophoretic trapping and determination of cell size | Buddying yeast cells (Saccharomyces cerevisiae) (~4–40 μm cell diameter); (testing particles: 6, 8 and 10 μm *PS beads) |
1 × 106 cells/mL 1 × 105−6 beads/mL 0.5 μL/min |
300 kHz to 10 MHz §NSVD 150 μm × 15 μm |
Magnitude | Geng et al. 2019132 |
PS = polystyrene;
NCCD = No cell concentration declared;
NFRD = No flow-rate declared;
NSVD = No signal voltage declared.